August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Supriya Peshin: FDA Approved Retifanlimab Combination for 1st Line Treatment of Advanced SCAC
May 30, 2025, 14:45

Supriya Peshin: FDA Approved Retifanlimab Combination for 1st Line Treatment of Advanced SCAC

Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared a post on X:

“Learned something new today in GI Oncclinic MD Anderson Cancer Center: FDA approved retifanlimab +carboplatin/paclitaxel for first-line treatment of advanced SCAC major step forward in care for Anal cancer.”

Read Full Blog on FDA.

Read More on OncoDaily’s special article: “FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal

Retifanlimab-dlwr FDA approval on OncoDaily FDA Approved